Greg Pyszczymuka

Corporate Officer/Principal presso AYTU BIOPHARMA, INC.

Patrimonio netto: 71 719 $ in data 31/05/2024

Health Technology

Consumer Services

Posizioni attive di Greg Pyszczymuka

Società	Posizione	Inizio	Fine
AYTU BIOPHARMA, INC.	Corporate Officer/Principal	01/01/2022	-

Società	Posizione	Inizio	Fine
NEOS THERAPEUTICS, INC.	Corporate Officer/Principal	01/11/2018	31/03/2021

Rutgers State University of New Jersey	Undergraduate Degree
Argosy University	Masters Business Admin

Distribuzione geografica

Stati Uniti	4
Francia	2

Posizioni

Corporate Officer/Principal	2
Undergraduate Degree	1
Masters Business Admin	1

Settori

Health Technology	3
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
AYTU BIOPHARMA, INC.	Health Technology

Aziende private	1
Neos Therapeutics, Inc. Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX.	Health Technology

Aziende private

Health Technology